CHRIS AMOS to Smoking Cessation
This is a "connection" page, showing publications CHRIS AMOS has written about Smoking Cessation.
Connection Strength
1.108
-
Chipping away at the genetics of smoking behavior. Nat Genet. 2010 May; 42(5):366-8.
Score: 0.291
-
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices. EBioMedicine. 2024 Dec; 110:105441.
Score: 0.199
-
The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials. Nicotine Tob Res. 2022 10 17; 24(10):1573-1580.
Score: 0.172
-
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. Clin Pharmacol Ther. 2020 12; 108(6):1315-1325.
Score: 0.148
-
Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine. 2016 Sep; 11:219-226.
Score: 0.112
-
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
Score: 0.102
-
Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. JAMA. 2015 Jan 13; 313(2):147-55.
Score: 0.025
-
An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4.
Score: 0.016
-
A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
Score: 0.015
-
Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
Score: 0.012
-
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998 Mar 04; 90(5):358-63.
Score: 0.008
-
Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
Score: 0.008